Sequential involvement of hypoxia and anti-PD-1 treatment in shaping tumor-regional CD39(+)CD8(+) T cells highlights immunotherapy-resistant features in NSCLC.

Wu J et al.

NCBI PubMed Central · Papers · License: Open Access

distributed systems architecture

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 323041
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.